MPS Pharmaa Ltd.

ADVIKLA

₹2.76

4.94% (0.13)

Market Cap

₹5 Cr.

P/E

0.00

About

Advik Laboratories Ltd focuses on achieving USFDA standards of quality with a product range including ethical drugs such as Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin, and Chewfe-… Read more

Advik Laboratories Ltd focuses on achieving USFDA standards of quality with a product range in… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Working Capital

Working capital of the company seems to be under control
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Share price

Share price has decreased over last 10 years more due to earnings
Capex vs ROCE

Roce of the company has decreased even without significant capex
Debt

Company might have issues servicing its debt
ROE

Roe has decreased vs 10 year trend
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on MPS Pharmaa Ltd. Business

What does MPS Pharmaa do?

Advik Laboratories Ltd is focused on achieving USFDA standards in pharmaceuticals. Their product range covers ethical, generic, and over the counter drugs in multiple therapeutic categories.

Who are the competitors of MPS Pharmaa?

MPS Pharmaa major competitors are Fabino Enterprises, Zyden Gentec, Ganga Pharma., Hemo Organic, Kobo Biotech, Secunderabad Health., Senbo Industries.
Market Cap of MPS Pharmaa is ₹5 Crs.
While the median market cap of its peers are ₹6 Crs.

Is MPS Pharmaa financially stable compared to its competitors?

MPS Pharmaa seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

MPS Pharmaa Ltd.

MPS Pharmaa Ltd.

About

Timeline

Company Timeline

6 Yes

1 Neutral

9 No

1 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Revenue Recognition

Promoter Holding

Depreciation Effect

Retail Holding

Price & Performance

Working Capital

Balance Sheet Strength

Share price

Capex vs ROCE

Debt

ROE

Sales Growth

Margin Stability

ROCE Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does MPS Pharmaa do?

Who are the competitors of MPS Pharmaa?

Is MPS Pharmaa financially stable compared to its competitors?

SIGN UP FOR FREE